1 Min Read
May 23 (Reuters) - Neurovive Pharmaceutical
* Neurovive to continue Neurostat clinical development after positive outcome in preclinical and clinical TBI studies Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.